SCHEMBL16984292

SCHEMBL16984292

C[C@@H]1CC12CN(C(=O)OC(C)(C)C)C2

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ USP2 O75604 1/20 0.44
▸ SMN1; SMN2 Q16637 1/20 0.44
▸ EPHX2 P34913 1/20 0.44
▸ NR1H2 P55055 2/20 0.42
▸ HPGD P15428 1/20 0.41
▸ RECQL P46063 1/20 0.40
▸ EPHX1 P07099 1/20 0.40
▸ KDM4E B2RXH2 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ THRB P10828 1/20 0.39
▸ CHRM2 P08172 1/20 0.39
▸ CHRM1 P11229 1/20 0.39
▸ CHRM3 P20309 1/20 0.39
▸ GPR119 Q8TDV5 3/20 0.37
▸ PTPN2 P17706 1/20 0.36
▸ PTPN1 P18031 1/20 0.36
▸ PTPN6 P29350 1/20 0.36
▸ DDB1 Q16531 1/20 0.36
▸ CRBN Q96SW2 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16984366 0.86 USP2 (0.44) USP2SMN1; SMN2EPHX2HPGDRECQL
SCHEMBL24716561 0.84 HPGD (0.42) USP2SMN1; SMN2EPHX2NR1H2HPGD
SCHEMBL16984145 0.84 HPGD (0.46) USP2SMN1; SMN2EPHX2NR1H2HPGD
SCHEMBL19852976 0.84 HPGD (0.46) USP2SMN1; SMN2EPHX2NR1H2HPGD
SCHEMBL30523509 0.83 EPHX2 (0.40) USP2SMN1; SMN2EPHX2NR1H2HPGD
SCHEMBL31171877 0.83 EPHX2 (0.40) USP2SMN1; SMN2EPHX2NR1H2HPGD
SCHEMBL30523528 0.83 EPHX2 (0.40) USP2SMN1; SMN2EPHX2NR1H2HPGD
SCHEMBL25258920 0.83 EPHX2 (0.40) USP2SMN1; SMN2EPHX2NR1H2HPGD
SCHEMBL8217780 0.82 USP2 (0.50) USP2SMN1; SMN2EPHX2HPGDRECQL
SCHEMBL16984146 0.82 USP2 (0.50) USP2SMN1; SMN2EPHX2HPGDRECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150216168-A1 USE OF SUBSTITUTED 2-AMIDOBENZIMIDAZOLES, 2-AMIDOBENZOXAZOLES AND 2-AMIDOBENZOTHIAZOLES OR SALTS THEREOF AS ACTIVE SUBSTANCES AGAINST ABIOTIC PLANT STRESS BAYER CROPSCIENCE AG (DE) 2015-08-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150216168-A1 USE OF SUBSTITUTED 2-AMIDOBENZIMIDAZOLES, 2-AMIDOBENZOXAZOLES AND 2-AMIDOBENZOTHIAZOLES OR SALTS THEREOF AS ACTIVE SUBSTANCES AGAINST ABIOTIC PLANT STRESS ABAT, AAK1, AGXT USP2 2328/4885SMN1; SMN2 4680/4885EPHX2 3201/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback